Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Uremic Pruritus peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Uremic Pruritus. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2021–2022 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 14 selected PubMed records and 2 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Uremic Pruritus unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03422653
PeptideScanner retained ClinicalTrials.gov record NCT03422653 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 26, 2022
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03636269
PeptideScanner retained ClinicalTrials.gov record NCT03636269 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 26, 2022
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03998163
PeptideScanner retained ClinicalTrials.gov record NCT03998163 at 2026-11-15T21:56:33.343Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was difelikefalin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 15, 2021
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Difelikefalin · 2022-04-26
ClinicalTrials.gov record NCT03422653
Completed at the retained observation.
Open attributed record →Difelikefalin · 2022-04-26
ClinicalTrials.gov record NCT03636269
Completed at the retained observation.
Open attributed record →Difelikefalin · 2021-10-15
ClinicalTrials.gov record NCT03998163
Completed at the retained observation.
Open attributed record →